Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02541604
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of MPDL3280A (Anti-PD-L1 Antibody) in Pediatric and Young Adult Participants With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

Advanced Solid Tumor

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

Atezolizumab

Age Groups: child | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN


No variant requirements are available.